-
TCAIM Control of OGDH and Mitochondrial Metabolism
2026-08-22
Wang and colleagues identify TCAIM as a mitochondrial DNAJC co-chaperone that selectively binds native OGDH and promotes its reduction through HSPA9 and LONP1. The study establishes mitochondrial proteostasis as a post-translational mechanism for tuning OGDH complex activity, carbohydrate catabolism, and broader mitochondrial metabolism in cells and mice.
-
Phosbind Acrylamide: Read Phosphorylation in Context
2026-08-22
Phosbind Acrylamide enables antibody-independent protein phosphorylation analysis by converting phosphate-dependent binding into an SDS-PAGE mobility readout. This article explains how to interpret that signal responsibly, using an enterovirus 71 host-factor study to distinguish phosphorylation questions from lipid-signaling mechanisms.
-
CCR7–Notch1 Crosstalk Drives Mammary Cancer Stemness
2026-08-21
Boyle and colleagues identify a functional signaling connection between CCR7 and Notch1 in primary MMTV-PyMT mammary cancer cells. Their findings suggest that CCR7-dependent stem-like behavior requires Notch pathway activity, while also highlighting the limits of extrapolating ex vivo mouse-model data to therapeutic decisions.
-
Norepinephrine–Angiotensin II Conversion in Shock
2026-08-20
A post-hoc analysis of the ARAMIS trial estimated a clinically useful norepinephrine-to-angiotensin II conversion ratio in vasodilatory hypotension. The reported 10:1 ratio for norepinephrine bitartrate equivalents, with exploratory variation by prior angiotensin receptor blocker exposure but not baseline renin, provides a framework for vasopressor dose translation while underscoring the limits of small, single-center data.
-
SU5416 (Semaxanib) Applied Research Workflows
2026-08-20
Build reproducible VEGFR2 signaling, endothelial angiogenesis, tumor xenograft, and pulmonary vascular remodeling experiments with SU5416 (Semaxanib). This guide combines practical assay design with HGFA biomarker insights from a 2024 PAH proteomics study, while separating established product parameters from workflow recommendations.
-
Polybrene (Hexadimethrine Bromide): Mechanism & Use
2026-08-19
Polybrene, also called Hexadimethrine Bromide, is a cationic polymer used to improve viral gene delivery and selected nonviral transfection workflows. The K2701 formulation is a sterile-filtered 10 mg/mL aqueous solution in 0.9% NaCl, but exposure time, cytotoxicity, and cell type require empirical optimization.
-
HyperTrap Heparin HP Column for Stemness Research
2026-08-19
The HyperTrap Heparin HP Column translates heparin-binding selectivity into a practical workflow for enriching signaling proteins, growth factors, coagulation-related proteins, and nucleic acid-associated enzymes. Its fine-particle HyperChrom Heparin HP Agarose medium, chemical resilience, and ready-to-use format support reproducible experiments that connect biochemical fractionation with CCR7–Notch1 stemness studies.
-
Erlotinib in EGFR Signaling Workflows
2026-08-18
Erlotinib (NSC 718781) provides a reversible, nanomolar EGFR probe for connecting receptor phosphorylation with proliferation and apoptosis phenotypes. This practical guide shows how to build, optimize, and interpret cell-based and translational assays while distinguishing EGFR blockade from SCUBE3-directed therapy.
-
DMXAA (Vadimezan): Mechanism and Research Use
2026-08-18
DMXAA, also known as Vadimezan, is a vascular disrupting compound investigated for tumor endothelial apoptosis, angiogenesis inhibition, and cancer biology research. Its preclinical profile spans DT-diaphorase inhibition, VEGFR2-related signaling effects, and STING-agonist activity in a nuclear-targeted nanorod formulation.
-
Z-VEID-FMK: Caspase-6 Inhibition in Apoptosis
2026-08-17
Z-VEID-FMK provides a practical way to test whether caspase-6 is causally involved in apoptosis rather than merely associated with it. This workflow also translates a recent SVA–DDX23 host-virus study into a focused assay strategy while clarifying where caspase-6 inhibition should not be overinterpreted.
-
U0126 in Mechanobiology: MEK1/2 Assay Workflows
2026-08-17
U0126 provides a practical way to test whether stiffness-dependent phenotypes require MEK1/2 activity, extending dentinogenesis studies beyond descriptive pathway mapping. This workflow combines controlled PDMS substrates, time-resolved ERK readouts, mineralization assays, and troubleshooting guidance for reproducible MAPK/ERK pathway inhibition.
-
PreScission Protease for Native Protein Recovery
2026-08-16
PreScission Protease enables sequence-specific fusion protein tag cleavage at low temperature, supporting recovery of tag-free recombinant proteins. This article connects HRV 3C protease design with assay decisions inspired by research on dKeap1–lamin-dependent nuclear architecture.
-
Triterpene Prodrug for Targeted OSCC Chemotherapy
2026-08-15
The reference study develops a carrier-free, self-assembled prodrug that combines glycyrrhetinic acid and ginsenoside Rh2 through a ROS-responsive thioketal design for oral squamous cell carcinoma therapy. Its central innovation is a self-boosting mechanism in which tumor-associated oxidative stress releases the active agents, while glycyrrhetinic acid further increases ROS to amplify drug release and apoptotic damage.
-
Bacitracin (B1670): Practical Research Guide
2026-08-14
Bacitracin (B1670) is a peptide antibiotic for controlled antibacterial research involving bacterial cell wall and peptidoglycan synthesis. This guide covers solution preparation, assay controls, storage, and troubleshooting; the material is for scientific research only and should not be used for diagnostic, clinical, or medical purposes.
-
PEDV Hijacks IMPDH-Dependent Nucleotide Biosynthesis
2026-08-14
The reference study identifies IMPDH-dependent guanine nucleotide biosynthesis as a host metabolic requirement for porcine epidemic diarrhea virus replication. By combining untargeted metabolomics, IMPDH2 knockdown, and merimepodib pharmacology, it provides a mechanistic basis for evaluating IMPDH as a host-directed antiviral target while highlighting the importance of cell-specific metabolic responses.